Navigation Links
Kessler Foundation awarded more than $1.2 million in grants by the NJ Commission on Sci Research

WEST ORANGE, N.J. -- The New Jersey Commission on Spinal Cord Injury Research awarded three grants to scientists at Kessler Foundation. The grants, which exceed $1.2 million, fund studies of assisted walking with Ekso, the impact of aging in the population with spinal cord injury (SCI) and the effects of electrical stimulation on bone loss.

"Thanks to the Commission, we have the ability to advance research to find new treatments that improve the function and quality of life of individuals with spinal cord injury," said John DeLuca, Ph.D., vice president for Research and Training at Kessler Foundation. "We look forward to combining our expertise in mobility and cognitive research to take the first step towards finding therapies that will delay deficits in thinking, learning and memory thought to be associated with the accelerated-aging process in people with SCI."

Gail Forrest, Ph.D., assistant director of Human Performance and Engineering Research, was awarded $574,976 over three years to study the effect of Ekso-assisted walking on muscle and bone (CSCR13IRG013). Ekso is a robotic battery-powered exoskeletal device made by Ekso Bionics. Dr. Forrest will determine whether a walking over-ground training protocol with Ekso can reverse negative changes in the muscles and bones of individuals with chronic SCI. Muscle volume and other indicators will be measured through magnetic resonance imaging (MRI) at the Neuroimaging Center at Kessler Foundation. Muscle expression for PGC-1aa protein responsible for energy metabolismand bone density will also be measured. In addition, changes in loading force, joint force and muscle activation will be assessed as individuals walk using the exoskeleton. Collected data will be used to design a multi-site clinical trial to determine whether a robotic exoskeleton training program is more effective in improving musculoskeletal outcomes than other current interventions.

Nancy Chiaravalloti, PhD, director of Neuropsychology & Neuroscience and Traumatic Brain Injury Research, and Jill Wecht, Ed.D., from James J. Peters Veterans Affairs Medical Center, received a three-year $596,152 grant to study the impact of aging on cardiovascular, cerebrovascular and cognitive health in individuals with SCI (CSCR13IRG018). Kessler Foundation's Trevor Dyson-Hudson, M.D., director of Spinal Cord Injury Research, and Glenn Wylie, D.Phil, assistant director of Neuroscience Research and the Neuroimaging Center, are co-investigators on the study. Accelerated cardiovascular aging, affecting the heart and blood circulation, is associated with a shorter life expectancy in SCI. Up to 60 percent also have some cognitive impairmentincluding deficits in attention, concentration, memory, reasoning and processing speedwhich challenges rehabilitation efforts and social integration. In the general population, aging is associated with cardiovascular dysfunction and cognitive slowing. This study will examine whether age-associated changes in cardiovascular function contribute to the increased prevalence of cognitive dysfunction in people with SCI. Cardiovascular data will be collected at rest, during activities of daily living and during cognitive assessments. The study aims to correlate clinical changes with functional MRI (fMRI) and diffusion tensor imaging (DTI) performed at the Neuroimaging Center at Kessler Foundation.

Megan Damcott, Ph.D., post-doctoral fellow in Human Performance and Engineering Research, received a one-year $50,000 grant to study the efficacy of electrical stimulation (ES) in preventing bone loss in individuals with SCI (CSCR13FEL009). The prolonged inability to walk decreases quality of life and causes bone loss and osteoporosis, which increases the risk of fractures and death. Dr. Damcott will develop a protocol for the use of ES with mechanical walking interventions. Once established, she will pilot a study to test the reliability and sensitivity of ES in preventing loss of bone density.

Contact: Lauren Scrivo
Kessler Foundation

Related biology news :

1. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
2. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
3. John A. Kaufman named 2012 Dotter Lecturer by Society of Interventional Radiology Foundation
4. Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced
5. 2012 ACMG Foundation/Signature Genomic Laboratories Travel Award winner announced
6. ASBMB wins National Science Foundation grant to enhance K-12 science education
7. UF receives $1 million from Keck Foundation to study mechanisms of inherited disease
8. Merkin Family Foundation to fund next generation of Broad Institute scientists
9. Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinsons drug development tools
10. New York Stem Cell Foundation scientist grows bone from human embryonic stem cells
11. National Psoriasis Foundation awards more than $2 million for research
Post Your Comments:
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... discussion at the Piper Jaffray 27th Annual Healthcare Conference ... is scheduled for Wednesday, December 2, at 8:00 a.m. ... will be available for 14 days after the event.  ... Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
(Date:11/24/2015)... SHPG ) announced today that Jeff Poulton , ... Annual Healthcare Conference in New York City ... (1:30 p.m. GMT). --> SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> Shire ...
Breaking Biology Technology: